OptiNose's novel intranasal sumatriptan product highly effective in treating migraines
Wednesday, April 7, 2010 - 12:22
in Health & Medicine
Oslo, April 7, 2010: OptiNose, a leader in nasal drug delivery systems, is pleased to announce the publication in Cephalalgia of results from its Phase II clinical study investigating the efficacy...